RecruitingNCT05699629
Prospective Coronary Heart Disease Cohort
A Prospective Longitudinal Multi-Omics Cohort of Patients With Coronary Heart Disease Undergoing Coronary Angiography
Sponsor
Shandong First Medical University
Enrollment
50,000 participants
Start Date
Jan 21, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
To evaluate the biomarkers for the prognosis of coronary heart disease, patients with coronary heart disease will be recruited and followed up for at least 2 years.
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- Diagnosed as coronary heart disease or with unexplained chest pain needed to undergo coronary angiography.
- Healthy subjects undergoing routine physical examination in the physical examination department and willing to sign informed consent will be recruited as control subjects.
Exclusion Criteria2
- With malignant tumors, infectious diseases and advanced liver diseases.
- Won't sign an inform consent.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05699629
Related Trials
The Next Leap in Cardiac Magnetic Resonance Imaging:Cycling the Field
NCT044588832 locations
Moderate Alcohol Consumption and Heart Function in Patients With a Recent Myocardial Infarction
NCT059206294 locations
Prevention of Reperfusion Injury Outcomes Through Effective Cardioprotection Targeting Myocardial Infarction
NCT073624465 locations
Heart Attack Research Program: Platelet Sub-Study (HARP)
NCT030225521 location
TeleheartCR vs. Clinic-Based Cardiac Rehabilitation After Acute Coronary Syndrome
NCT075410141 location